JULIA WILSON: Open Payments
NPI 1356994073 · LAWRENCEBURG, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,005 in 76 payments from 10 companies in 2025. Trend: 2023 $265 · 2024 $1,306 · 2025 $1,005
Food & beverage: $1,005
| Company | Payments | Amount |
|---|---|---|
| SCPHARMACEUTICALS INC. | 38 | $387 |
| Novartis Pharmaceuticals Corporation | 18 | $278 |
| PFIZER INC. | 4 | $66 |
| Merck Sharp & Dohme LLC | 3 | $54 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $50 |
| E.R. Squibb & Sons, L.L.C. | 3 | $49 |
| ABIOMED | 2 | $36 |
| Abbott Laboratories | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| Amgen Inc. | 1 | $22 |
Products named: FUROSCIX, LEQVIO, VERQUVO, Kerendia, CAMZYOS, VYNDAQEL, FARXIGA, ELIQUIS.
Industry payments across IN — which companies pay providers there.
